Strength
80 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001066701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA207777On Market Since
12/1/2025
Pharmacological Classes
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist
Related Drugs
Same classification
TOPIRAMATE 25 MG TABLET
Generic
00904692861•Major Pharmaceuticals
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011505•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011510•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011516•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
47335070713•Sun Pharmaceutical Industries Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
47335070786•Sun Pharmaceutical Industries Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
65862017160•Aurobindo Pharma Limited
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68084034201•American Health Packaging
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68382013805•Zydus Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68382013814•Zydus Pharmaceuticals (USA) Inc.
$0.0257
per EA